PLCG2 and Alzheimer disease: Moreover, GWAS studies (Sims et al., 2017) have found several AD disease risk factors that are linked to both phagocytosis and phosphoinositides including a hyper-functional protective variant of PLCγ2 which hydrolyzes PI(4,5)P2 (Magno et al., 2019).